A photo of Michael Sherenian.

Assistant Professor, UC Department of Pediatrics

513-636-8670

Board Certified

Make an Appointment

Visit the Sherenian Research Lab

My Biography & Research

Biography

Allergies are the most common health conditions among children throughout the United States. Researching the mechanisms behind allergic reactions is essential for reducing mortality rates and alleviating the symptoms of allergies for children nationwide.

My research focuses on studying and assessing the pathogenesis of allergic ailments, especially atopic dermatitis and its connection with clotting. My colleagues and I are attempting to determine the association between blood clotting and the development of allergic diseases. I also have research interests in asthma, fibrosis, food allergies, allergic rhinitis and the genetic foundation of allergic reactions.

I first became interested in these research topics during my fellowship when examining how an essential regulator of fibrinolysis affected asthma function in children. In terms of patient care, my specialty is caring for patients with allergic disorders, including atopic dermatitis, food allergies, allergic rhinitis and asthma.

I was drawn to working with children who have these conditions. Seeing how I could significantly improve children's quality of life by helping them manage their allergic reactions and alleviate their symptoms is inspiring. In 2015, I received a Pediatrics Board certification after completing my residency at the Cincinnati Children's Hospital Medical Center. By 2018, I achieved my allergy and immunology board certification. I have received K12 funding grants starting in 2018 to continue my research. In addition, in 2020, I received the American Academy of Allergy, Asthma and Immunology Faculty Development Award.

My research has been published in respected journals, such as Allergy, Asthma and Clinical Immunology, Annals of Allergy, Asthma and Immunology, Pediatrics and Journal of Allergy and Clinical Immunology-In Practice.

Clinical Interests

Atopic dermatitis (eczema); asthma; food allergies; allergic rhinitis; urticaria

Research Interests

Atopic dermatitis (eczema); asthma; food allergies; allergic rhinitis; fibrosis; genetic basis of allergic disease

Academic Affiliation

Assistant Professor, UC Department of Pediatrics

Clinical Divisions

Allergy and Immunology

Research Divisions

Asthma

My Locations

My Education

BS: Cornell University, Ithaca, NY 2008

MD: Drexel University College of Medicine, Philadelphia, PA, 2012.

MS: Northwestern University, Chicago, IL, 2018.

Residency: Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 2012-2015.

Fellowship: Allergy and Immunology, Ann and Robert H. Lurie Children's Hospital of Chicago/Northwestern University, Chicago, IL, 2015-2018.

Pediatrics Board Certification: 2015.

Allergy and Immunology Board Certification: 2018.

My Publications

Sensitization to peanut, egg or pets is associated with skin barrier dysfunction in children with atopic dermatitis. Sherenian, MG; Kothari, A; Biagini, JM; Kroner, JW; Baatyrbek kyzy, A; Johannson, E; Atluri, G; He, H; Martin, LJ; Khurana Hershey, GK. Clinical and Experimental Allergy. 2021; 51:666-673.

On the surface: Skin microbial exposure contributes to allergic disease. DeVore, SB; Gonzalez, T; Sherenian, MG; Herr, AB; Khurana Hershey, GK. Annals of Allergy, Asthma and Immunology. 2020; 125:628-638.

Events in Normal Skin Promote Early-Life Atopic Dermatitis-The MPAACH Cohort. Myers, JM B; Sherenian, MG; Kyzy, AB; Alarcon, R; An, A; Flege, Z; Morgan, D; Gonzalez, T; Stevens, ML; He, H; et al. Journal of Allergy and Clinical Immunology: In Practice. 2020; 8:2285-2293.e6.

The Mechanisms of Atopic Dermatitis to Asthma in Children (MPAACH) Cohort: Novel Atopic Dermatitis Endotypes. Myers, JB; Sherenian, M; Kyzy, AB; Alarcon, R; An, A; Flege, Z; Morgan, D; Gonzalez, T; Stevens, M; He, H; et al. Journal of Allergy and Clinical Immunology. 2020; 145.

The pediatric asthma risk score (PARS): making the move to the most accurate pediatric asthma risk screening tool. Sherenian, MG; Myers, JM B; Martin, LJ; Hershey, GK K. Expert Review of Clinical Immunology. 2019; 15:1115-1118.

Fetal cord blood and tissue immune responses to chronic placental inflammation and chorioamnionitis. Singh, AM; Sherenian, MG; Kim, KY; Erickson, KA; Yang, A; Mestan, K; Ernst, LM; Kumar, R. Canadian Journal of Allergy and Clinical Immunology. 2018; 14.

Association of food allergy and decreased lung function in children and young adults with asthma. Sherenian, MG; Singh, AM; Arguelles, L; Balmert, L; Caruso, D; Wang, X; Pongracic, J; Kumar, R. Annals of Allergy, Asthma and Immunology. 2018; 121:588-593.e1.

Plasminogen activator inhibitor 1 (PAI-1) level and lung function over 30 years: the CARDIA study. Sherenian, MG; Cuttica, MJ; Khan, SS; Colangelo, LA; Cook-Mills, J; Cho, SH; Fornage, M; Gross, M; Jacobs, D; Schreiner, P; et al. Journal of Allergy and Clinical Immunology. 2018; 141.

PAI-1 gain-of-function genotype, factors increasing PAI-1 levels, and airway obstruction: The GALA II Cohort. Sherenian, MG; Cho, SH; Levin, A; Min, J; Oh, SS; Hu, D; Galanter, J; Sen, S; Huntsman, S; Eng, C; et al. Clinical and Experimental Allergy. 2017; 47:1150-1158.

Title: PAI-1 Gain of Function Genotype and Airway Obstruction in Asthma. Sherenian, MG; Cho, SH; Levin, AM; Min, JY; Sen, S; Oh, S; Huntsman, S; Eng, C; Farber, HJ; Rodriguez-Cintron, W; et al. Journal of Allergy and Clinical Immunology. 2017; 139.